InsidersTradesSigma
Explore the detailed record of transactions filed by Breen Michael Martin, Director. Director active across 1 companies, notably GT Biopharma, Inc.. In total, 2 filings have been logged. The latest transaction was filed on 16 February 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Michael Martin Breen is a Board Member of GT Biopharma, Inc. As a member of the board, he participates in the governance of the company and strategic decision-making. Michael brings his expertise and experience to help guide the direction of the company. His role is essential in ensuring compliance and transparency in the operations of GT Biopharma, Inc.
